Home
Company
Funds
Team
Portfolio
News
Contact
Select Page
BPI FRANCE
BPI...
BNP PARIBAS
BNP...
European Investment Fund (EIF)
European Investment Fund...
Search for:
Recent Posts
Theranexus presents an update on the progress of its main programs and announces its cash position as of 31 December 2020. Implemantation of a new equity line.
Amolyt Pharma Receives Orphan Drug Designation for AZP-3601 for the Potential Treatment of Hypoparathyroidism
Theranexus, Lyon Neuroscience Research Center and CERMEP announce the creation and funding of new joint public/ private laboratory “NeuroImaging for Drug Discovery” (NI2D)
Amolyt Pharma announces research collaboration with PeptiDream
The Food and Drug Administration (FDA) issues a favorable opinion on the preclinical development plan submitted by Theranexus and BBDF
Recent Comments
Archives
January 2021
December 2020
November 2020
October 2020
September 2020
July 2020
April 2020
January 2020
December 2019
November 2019
October 2019
September 2019
July 2019
March 2019
February 2019
December 2018
November 2018
December 2017
September 2017
April 2017
Categories
News portfolio
Meta
Log in
Entries feed
Comments feed
WordPress.org
Recent Comments